OPEN LONGEVITY PROJECT

OPEN LONGEVITY PROJECT

Created using Figma
Created using Figma
Open Longevity is a community of people united by a common goal—to find and develop therapies extending youth. Our project aims to develop Open Longevity by creating an identically named online platform. On the one hand, it will serve as a personal cabinet with the possibility of obtaining expert advice and allowing one to form a personal strategy to combat aging. On the other hand, it will make it possible for the community itself to conduct clinical trials of antiaging therapies, bypassing the intermediary pharmaceutical corporations.
Risk: Very High
Sep 17, 2017
Dec 10, 2017
100% completed
$70 000
69
14% cap completed
Cap 500 000 USD
past
  • 1.5 YEAR
    =
    1 USD
Token Details
Ticker
YEAR
Accepted Currencies
ETH
Company Details
Registered Country
Russia
Additional Details
Categories
Platform, Health

About OPEN LONGEVITY PROJECT

What's Open Longevity?
An online platform consisting of a website and mobile app with the following capabilities:

  • Neural network
    Users upload their test results. Then the system gives advice on lifestyle, sports, nutrition and meds, based an array of data from the self-learning network.
  • Telemedicine
    A database of physicians, scientific analysts and biohackers to get your consultation, based on your personal data.
  • Research
    New infrastructure for scientists and volunteers to conduct and take part in research. Openness and refusal of patent protection will accelerate and reduce the cost of the process, increase the reliability of the results.
  • Marketplace
    Wearables and other diagnostic devices, dietary supplements and vitamins, applications and subscriptions for services, such as gyms, at special prices — everything for extra YEARs in one place.

Why do we think that the Open Longevity platform is interesting to millions of users?

Each of us wants to extend youth and improve the quality of life, our own and our loved ones. We all know, that the risks of so many diseases increase with age. We offer you to reduce these risks by performing the diagnostics in time. We will tell you how to do it and how to interpret the results. Our system is convenient for constant use, has high scientific certainty, relevance and flexibility. We rely on an array of scientific publications, not on the opinion of single experts. The value of such a service is obvious to everyone who wants to monitor their health and improve its performance.

OPEN LONGEVITY PROJECT Roadmap

  • Starting Q1 2018

  • Platform: The server part of the platform, API, allocation;
    Implementing YEAR;
    Patient card;
    Collection of markers, analyzes and images;
    Diagnostic panels;
    Data statistics;
    Access to foreign laboratories;
    Testing + QA.
    Diagnostics: Creating and interpreting new panels;
    Introduction of new panels.
    Text-based consultations.
    CI. Launch of the first Longevity Diet study.
  • Portfolio Tracking

  • The ability to track all major currencies against all major exchanges in a logical and concise manner.
  • Starting Q2 2018

  • Platform: Integration with laboratories (data acquisition without input);
    Development of iOS and Android applications;
    Integration with Gadgets;
    Customizable interface.
    Marketplace: Creating a platform.
    Diagnostics: BigData analytics;
    Text and image interpretation.
    Consultations: Communication with voice.
  • Portfolio Management

  • The ability to track all major currencies against all major exchanges in a logical and concise manner.
  • Read More
  • Starting Q3 2018

  • Platform: Loading external databases.
    Marketplace: Creating an API.
    CI: Creation of a platform for conducting CI.
    Consultations: Video consulting.
  • Portfolio Alerting

  • The ability to set fixed threshold alerts, or percentage of change alerts, that can be sent to a user's email or mobile device.
  • Starting Q4 2018

  • Platfrom: Integration with medical cards.
    Consultations: Rating system for doctors.
    CI: Voting system YEAR;
    Matching, selection of participants for CI;
    Launch the second study.
  • Public API

  • A free to use public API that gives users the ability to perform a number of operations against the folio.ninja dataset. Check out the documentation for more information.
  • Starting Q1 2019

  • Platform: Development of an external API platform.
    Diagnostics: Creating a neural network.
  • FLN Token listed on Exchanges - Q1 2018

  • The folio.ninja team will work with major cryptocurrency exchanges to list our ERC20 token - allowing users who were unable to participate in the crowdsale to obtain folio.ninja tokens, and those that did participate to speculate with their tokens value.
  • Starting Q2 2019

  • Platform: Implementing ZeroX.
    Diagnostics: Neaural network + PubMed;
    Predictors of geroprotectors;
    Neuronet + DNA;
    Neural network + Images.
  • API Integration Engine - Q2 2018

  • folio.ninja will start integration with supported exchanges. A supported exchange is defined as an exchange that has a publicly accessible and documented API with secure API key functionality. This is a fundamental component as it enables folio.ninja’s future features and services to collect and interact with other systems and provide a single pane of glass for viewing and executing on trade information.
  • Starting Q4 2019

  • Platform: Social network.
    CI: Launch of third study.
  • Mobile Application - Q3 2018

  • folio.ninja will develop an iOS and Android compatible mobile application that integrates seamlessly with all folio.ninja services and tools.
  • Automated Trading - Q4 2018

  • Automated investing is the process of setting predefined thresholds that will trigger a trade automatically once the thresholds are satisfied. These thresholds and interactions will change and develop over time as stipulated in the Whitepaper.
  • Social Trading Platform - Q1 2019

  • Social trading is the process through which online investors rely on community based user generated analytics and historical trades to make financial trading decisions to benefit their investment portfolios.
  • Arbitrage Trading Bot - Q2 2019

  • Arbitrage is the simultaneous purchase and sale of an asset in order to profit from a difference in asset price on different exchanges and marketplaces.
  • Machine Learning & AI Algorithms - Q3 2019

  • Machine Learning & AI algorithms can identify complex patterns in historical data that can be used to predict future trading outcomes.
  • Additional features and suggestions from the community

  • Ether Milestone: 10,000+ - To be used throughout the Roadmap for community driven suggestions and features and also milestone acceleration.The folio.ninja team will constantly be receiving feedback from initial contributors, users and the greater crypto community. We invite all users to participate in our Slack channel for discussions

Activity

Activity:
180
MEDIUM
Posts:
167
LOW
Views:
4 023
MEDIUM
Activity:
462
VERY HIGH
Merit:
105
MEDIUM
Posts:
624
HIGH
Views:
8 915
HIGH
Users:
86
LOW
Posts (30 days):
202
MEDIUM
Followers:
3 853
MEDIUM
Followers:
969
LOW
Tweets:
56
LOW
Alexa
Rank:
6 673 714
VERY LOW
Delta:
1 270 957
Year commits:
4
Watchers:
3
Stars:
2
Forks:
1
Open issues:
0

Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Head of Biological Data Standardization Department
unverified

Advisors

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Advisor
unverified

Last News

  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.
Planning an ICO? We can help with a wide range of support for all stages of your ICO